Used as an intermediate in the synthesis of fluoroquinolone antibiotics, particularly in the development of advanced antimicrobial agents targeting resistant bacterial strains. Its structure supports enhanced penetration into bacterial cells and improved binding to DNA gyrase and topoisomerase IV, making it valuable in creating drugs with broad-spectrum activity. Commonly employed in pharmaceutical research to optimize potency, pharmacokinetics, and reduce side effects in next-generation quinolones.